NEW FEATURES OF NON-DRUG TREATMENT OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WITH CONCOMITANT HYPERTENSION

Relevance. Non-alcoholic fatty liver disease (NAFLD) — one of the most common diffuse liver disease among individuals older than 40 years, which often accompanies aretrial hypertension (AH). The algorithms developed drug treatment comorbidity do not always satisfy their results may be accompanied by a certain refractory and side effects of therapy. Therefore relevant is the development of methods for the treatment of NAFLD with concomitant hypertension through the use of natural and preformed physical factors.

Аim of the course study the effectiveness of the internal use of an aqueous solution of bischofite of the Poltava field of NAFLD patients with concomitant hypertension.

Materials and methods: 40 patients with NAFLD with concomitant hypertension; anamnestic, clinical, biochemical and immunochemical methods, sonographic study of the digestive system, ambulatory BP monitoring, statistics.

Results the use of an aqueous solution of bischofite improves the clinical course of the underlying disease (p<0.05), concomitant diseases of the biliary tract (p<0.02) and IBS with constipation (p<0.003), improves the functional state of the liver and blood lipid (р<0.02), significantly reducing insulin resistance (p<0.01), primarily due to reduction of hyperinsulinemia (p<0.01), has a positive effect on circadian blood pressure profile at the expense of the average values of systolic and diastolic blood pressure.

Conclusion. The studies show high efficacy of non-drug treatment provider multidirectional and multifaceted effects on NAFLD patients with concomitant hypertension.